endostar
Showing 1 - 25 of 41
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Endostar
- Toripalimab
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 17, 2023
Advanced Pancreatic Cancer Trial in Xuzhou (Envafolimab, Endostar, Nab paclitaxel)
Not yet recruiting
- Advanced Pancreatic Cancer
- Envafolimab
- +3 more
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Mar 18, 2022
Nasopharyngeal Carcinoma Trial in Nanchang (Endostar)
Recruiting
- Nasopharyngeal Carcinoma
- Endostar
-
Nanchang, Jiangxi, ChinaXiaochang Gong
Dec 15, 2021
Nasopharyngeal Carcinoma Trial in Nanning (endostar, DDP, IMRT)
Completed
- Nasopharyngeal Carcinoma
- endostar
- +2 more
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Jan 30, 2022
Advanced or Metastatic NSCLC Trial in Shanghai (drug, device, combination product)
Not yet recruiting
- Advanced or Metastatic NSCLC
- Endostar
- +2 more
-
Shanghai, Shanghai, ChinaLan Mu
Jun 29, 2021
Nasopharyngeal Tumors Trial (endostar, intensity modulated radiation, cisplatin)
Completed
- Nasopharyngeal Neoplasms
- endostar
- +2 more
- (no location specified)
Jun 22, 2020
Soft Tissue Sarcoma, Adult, Stage IIB Trial in Tianjin (Endostar, Placebo, AIM regimen / GT regimen)
Completed
- Soft Tissue Sarcoma, Adult, Stage IIB
- Endostar
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Hospital & Institute
Dec 23, 2019
Non-squamous NSCLC Trial in Chongqing (endostar/PD-1 inhibitor, endostar)
Unknown status
- Non-squamous Non-small Cell Lung Cancer
- endostar/PD-1 inhibitor
- endostar
-
Chongqing, Chongqing, ChinaDaping Hospital, Third Military Medical University
Aug 19, 2019
Nasopharyngeal Carcinoma Trial (Endostar, Cisplatin, Docetaxel)
Not yet recruiting
- Nasopharyngeal Carcinoma
- Endostar
- +3 more
- (no location specified)
Apr 28, 2019
Breast Cancer Trial in Hangzhou (Endostar, Chemotherapy)
Unknown status
- Breast Cancer
- Endostar
- Chemotherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Apr 5, 2019
Nasopharyngeal Tumors Trial in Changsha (Endostar)
Unknown status
- Nasopharyngeal Neoplasms
- Endostar
-
Changsha, Hunan, Chinathe Second Xiangya Hospital
Jan 29, 2019
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Irinotecan, DDP, Endostar)
Unknown status
- Esophageal Squamous Cell Carcinoma
- Irinotecan
- +2 more
-
Shanghai, Shanghai, ChinaCancer hospital Fudan University
Jan 7, 2019
Lung Cancer Trial in Guangzhou (Endostar, Docetaxel, Carboplatin)
Unknown status
- Lung Cancer
- Endostar
- +3 more
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital & Institute of Guangzhou Medical Univ
Oct 15, 2018
NSCLC Trial in Wuhan (endostar, Placebos, radiotherapy)
Unknown status
- Non-small Cell Lung Cancer
- endostar
- +2 more
-
Wuhan, Hubei, ChinaUnion Hospital
Jul 29, 2018
Radiation Pneumonitis, Endostatin Trial in Chongqing (Endostar, standard SRILI treatment)
Unknown status
- Radiation Pneumonitis
- Endostatin
- Endostar
- standard SRILI treatment
-
Chongqing, ChinaXinqiao Hospital of Chongqing
Jan 7, 2019
Non Small Cell Lung Cancer Trial (Endostar, Gemcitabine, Cisplatin)
Unknown status
- Non Small Cell Lung Cancer
- Endostar
- +2 more
- (no location specified)
Apr 18, 2017
Cervical Carcinoma Trial in Nanning (Endostar, DDP)
Unknown status
- Cervical Carcinoma
- Endostar
- DDP
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Mar 16, 2017
Nasopharyngeal Carcinoma Trial in Nanning (Endostar, DDP)
Unknown status
- Nasopharyngeal Carcinoma
- Endostar
- DDP
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Sep 15, 2016
Angiogenesis, Breast Cancer Trial (endostar)
Unknown status
- Angiogenesis
- Breast Cancer
- endostar
- (no location specified)
Aug 11, 2016
Malignant Hydrothorax, Non Small Cell Lung Cancer Trial (Gemcitabine, Vinorelbine, Paclitaxel)
Unknown status
- Malignant Hydrothorax
- Non Small Cell Lung Cancer
- Gemcitabine
- +6 more
- (no location specified)
Oct 20, 2016
Neuroblastoma Trial in Shanghai (Endostar, 21.6Gy/12Fx to the tumor bed and 36Gy/20Fx to the tumor)
Unknown status
- Neuroblastoma
- Endostar
- 21.6Gy/12Fx to the tumor bed and 36Gy/20Fx to the tumor
-
Shanghai, Shanghai, ChinaThe Department of Radiation Oncology, Xin Hua Hospital Affiliate
Jun 12, 2016
Esophageal Squamous Cell Carcinoma Trial in Shanghai (NVB, DDP, Endostar)
Unknown status
- Esophageal Squamous Cell Carcinoma
- NVB
- +2 more
-
Shanghai, Shanghai, ChinaCancer hospital Fudan University
Jan 24, 2016
NSCLC Trial in Nanjing (Endostar, Chemotherapy)
Unknown status
- NSCLC
- Endostar
- Chemotherapy
-
Nanjing, Jiangsu, ChinaJiangsu Province Cancer Hospital
Jan 8, 2016